312 related articles for article (PubMed ID: 22107336)
1. ACR appropriateness criteria(®) ductal carcinoma in situ.
Moran MS; Bai HX; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; MacDonald SM; Haffty BG;
Breast J; 2012; 18(1):8-15. PubMed ID: 22107336
[TBL] [Abstract][Full Text] [Related]
2. ACR Appropriateness Criteria® Ductal Carcinoma in Situ.
Kaufman SA; Harris EE; Bailey L; Chadha M; Dutton SC; Freedman GM; Goyal S; Halyard MY; Horst KC; Novick KL; Park CC; Suh WW; Toppmeyer D; Zook J; Haffty BG
Oncology (Williston Park); 2015 Jun; 29(6):446-58, 460-1. PubMed ID: 26089220
[TBL] [Abstract][Full Text] [Related]
3. ACR Appropriateness Criteria® local-regional recurrence (LR) and salvage surgery: breast cancer.
Halyard MY; Wasif N; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Horst KC; Moran MS; MacDonald SM; Haffty BG;
Am J Clin Oncol; 2012 Apr; 35(2):178-82. PubMed ID: 22433995
[TBL] [Abstract][Full Text] [Related]
4. ACR appropriateness criteria® locally advanced breast cancer.
Macdonald SM; Harris EE; Arthur DW; Bailey L; Bellon JR; Carey L; Goyal S; Halyard MY; Horst KC; Moran MS; Haffty BG
Breast J; 2011; 17(6):579-85. PubMed ID: 21906206
[TBL] [Abstract][Full Text] [Related]
5. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
7. ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer.
Halyard MY; Harris EE; Bailey L; Bellon JR; Freedman GM; Goyal S; Horst KC; Moran MS; Park CC; Suh WW; Toppmeyer D; Haffty BG
Oncology (Williston Park); 2014 Feb; 28(2):157-64, C3. PubMed ID: 24701707
[TBL] [Abstract][Full Text] [Related]
8. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
9. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
10. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
[TBL] [Abstract][Full Text] [Related]
11. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and factors impacting local recurrence of ductal carcinoma in situ.
Weng EY; Juillard GJ; Parker RG; Chang HR; Gornbein JA
Cancer; 2000 Apr; 88(7):1643-9. PubMed ID: 10738223
[TBL] [Abstract][Full Text] [Related]
13. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
[TBL] [Abstract][Full Text] [Related]
14. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ.
Williamson D; Dinniwell R; Fung S; Pintilie M; Done SJ; Fyles AW
Radiother Oncol; 2010 Jun; 95(3):317-20. PubMed ID: 20400190
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
17. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
18. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
[TBL] [Abstract][Full Text] [Related]
19. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
